You are here

  • Home
  • Archive
  • Volume 69, Issue 12
  • Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

Article metrics

Article menu
Download PDFPDF
Hepatology
Original research
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

 

Online download statistics by month:

Online download statistics by month: March 2020 to March 2024

AbstractFullPdf
Mar 20206467742
Apr 20207819160
May 20203324737
Jun 20202735430
Jul 2020100228
Aug 20201583335
Sep 2020101198
Oct 20201673932
Nov 202069010985
Dec 20203436143
Jan 20213155337
Feb 20212023129
Mar 20212052919
Apr 20213033325
May 2021682415
Jun 202112128
Jul 202115139
Aug 2021201810
Sep 2021232114
Oct 202165189
Nov 20211051813
Dec 202180149
Jan 20221161715
Feb 202294104
Mar 20221552711
Apr 202212394
May 2022159145
Jun 2022174214
Jul 2022971210
Aug 2022118118
Sep 202291138
Oct 20229396
Nov 20226584
Dec 20228466
Jan 20237563
Feb 202313352
Mar 202383912
Apr 20234542
May 20234497
Jun 20233492
Jul 20234142
Aug 20232950
Sep 20234551
Oct 202362911
Nov 202357128
Dec 20237211
Jan 20244355
Feb 20242741
Mar 20245654
Total72191085723